Team:Westminster/Notebook
From 2012.igem.org
Line 1: | Line 1: | ||
- | |||
- | |||
<html> | <html> | ||
+ | |||
<head> | <head> | ||
- | <style type="text/css"> | + | |
- | + | <meta http-equiv="content-type" content="text/php; charset=utf-8" /> | |
- | + | ||
- | + | <style type="text/css"> | |
- | + | @import url 'http://yui.yahooapis.com/2.9.0/build/reset/reset-min.css'; | |
- | + | ul { | |
- | + | list-style: none; | |
- | + | } | |
- | + | body { | |
- | } | + | font-family: "HelveticaNeue-Light", "Helvetica Neue Light", "Helvetica Neue", Helvetica, Arial, "Lucida Grande", sans-serif; |
- | + | font-weight: 300; | |
- | + | background: url("http://www.westminsterigem.com/files/theme/body-bg.png") repeat #ffffff; | |
- | + | color: #666666; | |
- | + | } | |
- | + | h1, h2 { | |
- | } | + | color: #ff0000; |
- | div# | + | font-size: 18pt; |
- | + | margin-bottom: 0.5em; | |
- | } | + | } |
- | div# | + | h2 { |
- | + | font-size: 16pt; | |
- | + | } | |
- | } | + | h3 { |
- | + | color: #ff0000; | |
- | + | } | |
- | + | p { | |
- | } | + | |
- | ul#navigation > li { | + | } |
- | + | a { | |
- | + | ||
- | + | } | |
- | + | #p-logo { | |
- | } | + | background: #444444; |
- | ul#navigation > li. | + | } |
- | + | div#top-section, | |
- | } | + | div#content { |
- | ul#navigation > li. | + | box-shadow: 0px 0px 17px -4px #666666; |
- | + | } | |
- | + | div#wrapper { | |
- | } | + | position: relative; |
- | ul#navigation a.navlink { | + | width: 885px; |
- | + | font-size: 12pt; | |
- | + | padding: 50px 40px; | |
- | + | margin: 0 auto; | |
- | + | background: #ffffff; | |
- | + | } | |
- | } | + | div#header { |
- | ul#navigation a.navlink:hover { | + | height: 185px; |
- | + | } | |
- | + | div#header div#logo { | |
- | + | position: relative; | |
- | } | + | width: 400px; |
- | div#footer-box { | + | height: 125px; |
- | + | margin: 0 auto; | |
- | } | + | } |
- | </style> | + | div#header div#logo { |
+ | margin-bottom: 20px; | ||
+ | } | ||
+ | div#navigation { | ||
+ | width: 100%; | ||
+ | height: 40px; | ||
+ | background: #000000; | ||
+ | } | ||
+ | ul#navigation-list { | ||
+ | height: 40px; | ||
+ | line-height: 40px; | ||
+ | overflow: hidden; | ||
+ | } | ||
+ | ul#navigation-list > li { | ||
+ | float: left; | ||
+ | } | ||
+ | ul#navigation-list > li > ul { | ||
+ | position: absolute; | ||
+ | display: none; | ||
+ | background: #000000; | ||
+ | z-index: 100000; | ||
+ | } | ||
+ | ul#navigation-list > li > ul.submenu { | ||
+ | margin: 0; | ||
+ | } | ||
+ | ul#navigation-list > li > ul.submenu li { | ||
+ | padding: 5px 0px; | ||
+ | } | ||
+ | ul#navigation-list a.navlink { | ||
+ | color: #ffffff; | ||
+ | font-weight: bold; | ||
+ | display: block; | ||
+ | padding: 0px 14px; | ||
+ | text-decoration: none; | ||
+ | } | ||
+ | ul#navigation-list a.navlink.active, | ||
+ | ul#navigation-list a.navlink:hover { | ||
+ | color: #ff0000; | ||
+ | } | ||
+ | div#home-main-image { | ||
+ | text-align: center; | ||
+ | } | ||
+ | div#home-main-image img { | ||
+ | width: 885px; | ||
+ | height: 300px; | ||
+ | margin-bottom: 20px; | ||
+ | border-radius: 20px; | ||
+ | } | ||
+ | div.text-box { | ||
+ | background: #444444; | ||
+ | color: #ffffff; | ||
+ | padding: 15px 20px; | ||
+ | border-radius: 10px; | ||
+ | } | ||
+ | div.three-columns { | ||
+ | padding-left: 20px; | ||
+ | overflow: auto; | ||
+ | } | ||
+ | div.column, img.column { | ||
+ | float: left; | ||
+ | width: 235px; | ||
+ | margin: 10px 0px 50px 20px; | ||
+ | border-radius: 10px; | ||
+ | } | ||
+ | div.centered { | ||
+ | position: relative; | ||
+ | width: 400px; | ||
+ | margin: 10px auto; | ||
+ | } | ||
+ | div#footer-box { | ||
+ | border-radius: 0 0 5px 5px; | ||
+ | } | ||
+ | </style> | ||
+ | |||
+ | <script type="text/javascript" src="http://code.jquery.com/jquery-1.8.2.min.js"></script> | ||
+ | <script type="text/javascript"> | ||
+ | $('document').ready(function() { | ||
+ | $('li.submenu-holder').hover(function() { | ||
+ | $(this).children('ul.submenu').stop(true).fadeIn('slow'); | ||
+ | }, function() { | ||
+ | $(this).children('ul.submenu').stop(true).fadeOut('slow'); | ||
+ | }); | ||
+ | }); | ||
+ | </script> | ||
+ | |||
</head> | </head> | ||
<body> | <body> | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
+ | <div id="wrapper"> | ||
- | + | <div id="header"> | |
+ | <div id="logo"> | ||
+ | <a href="https://2012.igem.org/Team:Westminster"> | ||
+ | <img src="https://static.igem.org/mediawiki/2012/1/1e/Westminster-logo.png" alt="iSTEM" title="Back to home!" /> | ||
+ | </a> | ||
+ | </div><!-- #logo --> | ||
+ | <div id="navigation"> | ||
+ | <ul id="navigation-list"> | ||
+ | <li><a href="https://2012.igem.org/Team:Westminster" class="navlink">Home</a></li> | ||
+ | <li><a href="https://2012.igem.org/Team:Westminster/Team" class="navlink">Team</a></li> | ||
+ | <li><a href="https://igem.org/Team.cgi?year=2012&team_name=Westminster"class="navlink">Team Profile</a></li> | ||
+ | <li class="submenu-holder"> | ||
+ | <a href="https://2012.igem.org/Team:Westminster/Project/Overview"class="navlink active">Project</a> | ||
+ | <ul class="submenu"> | ||
+ | <li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Overview"class="navlink active">Overview</a></li> | ||
+ | <li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Problem"class="navlink">The Problem</a></li> | ||
+ | <li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Experiments"class="navlink">Experiments</a></li> | ||
+ | <li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Protocols"class="navlink">Protocols</a></li> | ||
+ | <li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Results"class="navlink">Results</a></li> | ||
+ | <li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Safety"class="navlink">Safety</a></li> | ||
+ | <li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Journal"class="navlink">Journal</a></li> | ||
+ | </ul> | ||
+ | </li> | ||
+ | <li><a href="https://2012.igem.org/Team:Westminster/Parts"class="navlink">Parts</a></li> | ||
+ | <li><a href="https://2012.igem.org/Team:Westminster/Modeling"class="navlink">Modeling</a></li> | ||
+ | <li><a href="https://2012.igem.org/Team:Westminster/Notebook"class="navlink">Notebook</a></li> | ||
+ | <li><a href="https://2012.igem.org/Team:Westminster/Safety"class="navlink">Safety</a></li> | ||
+ | <li><a href="https://2012.igem.org/Team:Westminster/Attributions"class="navlink">Attributions</a></li> | ||
+ | </ul><!-- #navigation-list --> | ||
+ | </div><!-- #navigation --> | ||
+ | </div><!-- #header --> | ||
+ | |||
+ | <div id="the-content"> | ||
+ | <div id="home-main-image"> | ||
+ | <img src="https://static.igem.org/mediawiki/2012/4/4d/Westminster_team.png" alt="Welcome" title="Welcome to our home!" /> | ||
+ | </div><!-- #home-main-image --> | ||
+ | |||
+ | <div id="home-main-text"> | ||
+ | <h2>Lorem Ipsum</h2> | ||
+ | <p>Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.</p> | ||
+ | <h2>Lorem Ipsum</h2> | ||
+ | <p>Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.</p> | ||
+ | <h2>Lorem Ipsum</h2> | ||
+ | <p>Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.</p> | ||
+ | </div><!-- #home-main-text --> | ||
+ | |||
+ | </div><!-- #the-content --> | ||
+ | |||
+ | </div><!-- #wrapper --> | ||
+ | |||
+ | |||
+ | </body> | ||
+ | |||
+ | </html> |
Revision as of 20:10, 25 September 2012
Lorem Ipsum
Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.
Lorem Ipsum
Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.
Lorem Ipsum
Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.